Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Research on Disease Burden of CRE (including non-MBL and MBL-CRE), CR-PA and Stenotrophomonas Maltophilia in ChinaRelease Date:Research Hospital China Addressing Barriers to Cancer Care for AIAN and NHPI IndividualsQuality Improvement Oncology USA Educational approaches to address immunization practice gaps and improve adult vaccination coverage in SwitzerlandRelease Date:Education Vaccines Switzerland Improving Patient Care of Lower Respiratory Tract Infection Among InfantsRelease Date:Quality Improvement Vaccines Thailand China Medical Education in Non-small Cell Lung Cancer Diagnosis, Treatment and Long-Term Disease ManagementRelease Date:Education Oncology China Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology France, Germany, Italy, Japan, Spain, USA, United Kingdom Healthcare Optimization and Patient Equity for Lung Cancer in China (“HOPE”)Release Date:Partner: The International Association for the Study of Lung Cancer (IASLC)Quality Improvement Oncology China Optimizing ER+ Metastatic Breast Cancer Treatment: incorporating emerging treatment options and biomarker testingEducation Oncology All Optimizing vaccination pathways among at-risk or immunocompromised adults and the elderly in ItalyRelease Date:Quality Improvement Vaccines Italy Expanding Access to Maternal Immunization Resources and Point-of-Care ToolsRelease Date:Education Vaccines USA Optimizing ATTR-CM Diagnosis and Care in Heart Failure Patients Quality Improvement Grant Program Request for ProposalsRelease Date:Partner: American College of CardiologyQuality Improvement Rare Disease USA Optimizing maternal immunization practice in Saudi ArabiaRelease Date:Quality Improvement Vaccines Saudi Arabia Title Grant Type Focus Area Country Application Due Date Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory ConditionsRelease Date:Review Process:Improving the Clinical Management of Uncontrolled AcromegalyRelease Date:Review Process:Antimicrobial Stewardship in the Asia-Pacific RegionRelease Date:Review Process:Lysosomal Storage Disorders Fellowship for Nurse PractitionersRelease Date:Review Process:Hemophilia PUP RegistryRelease Date:Review Process:Quality Improvement Initiatives:Improving Screening and Diagnosis of Atrial Fibrillation and Optimizing Treatment and ManagementRelease Date:Review Process:Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory ConditionsRelease Date:Review Process:Accelerating the Detection, Diagnosis and Initial Treatment of Psoriatic ArthritisRelease Date:Review Process:Improving the Identification and Management of Patients with Atrial Fibrillation (AF) and venous thromboembolism (VTE)Release Date:Review Process:Medication Optimization in Primary CareRelease Date:Review Process:Quality Improvement Activities to Prevent Fatal Pulmonary ThromboembolismRelease Date:Review Process:Increasing Rates of BRCA Testing in Patients with Breast CancerRelease Date:Review Process: